NO20053133L - Kjemiske forbindelser. - Google Patents

Kjemiske forbindelser.

Info

Publication number
NO20053133L
NO20053133L NO20053133A NO20053133A NO20053133L NO 20053133 L NO20053133 L NO 20053133L NO 20053133 A NO20053133 A NO 20053133A NO 20053133 A NO20053133 A NO 20053133A NO 20053133 L NO20053133 L NO 20053133L
Authority
NO
Norway
Prior art keywords
formula
optionally substituted
independently selected
chemical connections
tebazolyl
Prior art date
Application number
NO20053133A
Other languages
English (en)
Norwegian (no)
Other versions
NO20053133D0 (no
Inventor
Michael Barry Gravestock
Folkert Reck
Fei Zhou
Nail James Hales
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0227704A external-priority patent/GB0227704D0/en
Priority claimed from GB0310828A external-priority patent/GB0310828D0/en
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20053133D0 publication Critical patent/NO20053133D0/no
Publication of NO20053133L publication Critical patent/NO20053133L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20053133A 2002-11-28 2005-06-27 Kjemiske forbindelser. NO20053133L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0227704A GB0227704D0 (en) 2002-11-28 2002-11-28 Chemical compounds
GB0310828A GB0310828D0 (en) 2003-05-10 2003-05-10 Chemical compounds
PCT/GB2003/005091 WO2004048350A2 (en) 2002-11-28 2003-11-24 Oxazolidinones as antibacterial agents

Publications (2)

Publication Number Publication Date
NO20053133D0 NO20053133D0 (no) 2005-06-27
NO20053133L true NO20053133L (no) 2005-07-15

Family

ID=32395888

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20053133A NO20053133L (no) 2002-11-28 2005-06-27 Kjemiske forbindelser.

Country Status (12)

Country Link
US (1) US7498350B2 (ar)
EP (1) EP1581524A2 (ar)
JP (1) JP2006515601A (ar)
KR (1) KR20050084010A (ar)
AU (1) AU2003285509A1 (ar)
BR (1) BR0316690A (ar)
CA (1) CA2507628A1 (ar)
MX (1) MXPA05005522A (ar)
NO (1) NO20053133L (ar)
SA (1) SA04250095A (ar)
TW (1) TW200533667A (ar)
WO (1) WO2004048350A2 (ar)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL163688A0 (en) 2002-02-28 2005-12-18 Astrazeneca Ab 3-Cyclyl-5-(nitrogen-containing 5-membered ring)methyl-oxazolidinone derivatives and theiruse as antibacterial agents
BR0308018A (pt) 2002-02-28 2005-01-04 Astrazeneca Ab Composto ou um seu sal farmaceuticamente aceitável ou um seu éster hidrolisável in vivo, pró-droga, método para produzir um efeito antibacteriano em um animal de sangue quente, uso de um composto ou um seu sal farmaceuticamente aceitável ou um seu éster hirolisável in vivo, composição farmacêutica, e, processo para a preparação de um composto ou um seu sal farmaceuticamente aceitável ou um seu éster hidrolisável in vivo
JP4607107B2 (ja) * 2003-07-02 2011-01-05 メルク・シャープ・エンド・ドーム・コーポレイション シクロプロピル基置換されたオキサゾリジノン抗生物質およびこれらの誘導体
KR100854211B1 (ko) 2003-12-18 2008-08-26 동아제약주식회사 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
JP2008500318A (ja) * 2004-05-25 2008-01-10 アストラゼネカ アクチボラグ 抗菌剤としての3−{4−(ピリジン−3−イル)フェニル}−5−(1h−1,2,3−トリアゾール−1−イルメチル)−1,3−オキサゾリジン−2−オン
WO2007023507A2 (en) * 2005-06-20 2007-03-01 Wockhardt Limited Oxazolidinones bearing antimicrobial activity composition and methods of preparation
CA2664572C (en) 2006-09-25 2015-06-16 Wockhardt Research Centre Substituted piperidinophenyl oxazolidinones
WO2008069619A1 (en) * 2006-12-08 2008-06-12 Legochem Bioscience Ltd. Novel oxazolidinone derivatives, process for preparing thereof and pharmaceutical composition containing the same
JP5236246B2 (ja) * 2007-10-18 2013-07-17 株式会社クラレ スルホニルハライド誘導体の製造方法
JP5352387B2 (ja) * 2008-09-02 2013-11-27 株式会社クラレ スルトン誘導体の製造方法
MX2011003820A (es) 2008-10-10 2011-06-16 Trius Therapeutics Metodos para preparar oxazolidinonas y composiciones que las contienen.
SG10201500207QA (en) 2009-02-03 2015-03-30 Merck Sharp & Dohme Crystalline form of r)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate
US8580767B2 (en) 2009-05-28 2013-11-12 Trius Therapeutics, Inc. Oxazolidinone containing dimer compounds, compositions and methods to make and use
KR101128029B1 (ko) 2010-03-08 2012-03-29 주식회사 레고켐 바이오사이언스 (r)-3-(3-플루오로-4-(1-메틸-5,6-다이하이드로-1,2,4-트리아진-4(1h)-일)페닐)-5-(치환된 메틸)옥사졸리딘-2-온 유도체의 제조방법
FR2975990B1 (fr) * 2011-06-01 2013-05-24 Rhodia Operations Procede de preparation d'un compose organique fluore
TW201609651A (zh) 2013-11-12 2016-03-16 陶氏農業科學公司 用於氟化化合物之過程(一)
BR102014028164A2 (pt) 2013-11-12 2015-09-08 Dow Agrosciences Llc processo para fluoração de compostos
BR102014028162A2 (pt) 2013-11-12 2015-09-08 Dow Agrosciences Llc processo para fluoração de compostos
KR101561964B1 (ko) 2013-11-15 2015-10-20 한국과학기술연구원 옥사졸리디논 화합물 및 이를 포함하는 c형 간염 예방 또는 치료용 약학 조성물
WO2016061772A1 (en) 2014-10-22 2016-04-28 Merck Sharp & Dohme Corp. Nargenicin compounds and uses thereof as antibacterial agents
TWI726900B (zh) 2015-08-04 2021-05-11 美商陶氏農業科學公司 用於氟化化合物之過程
KR101855334B1 (ko) * 2015-12-11 2018-06-08 에스티팜 주식회사 옥사졸리디논 유도체의 중간체 제조방법
WO2019118311A1 (en) 2017-12-13 2019-06-20 Merck Sharp & Dohme Corp. Pharmaceutical compositions of tedizolid phosphate
WO2019173548A1 (en) * 2018-03-07 2019-09-12 Cyclerion Therapeutics, Inc. Process for preparing soluble guanylate cyclase stimulators
MX2022016063A (es) 2020-06-18 2023-04-11 Akagera Medicines Inc Compuestos de oxazolidinona, composiciones de liposomas que comprenden compuestos de oxazolidinona y metodos de uso de los mismos.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0009803D0 (en) * 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
EP1289984A4 (en) * 2000-06-05 2004-11-24 Dong A Pharm Co Ltd NEW OXAZOLIDE DERIVATIVES AND A METHOD FOR THEIR PRODUCTION
US20020115669A1 (en) 2000-08-31 2002-08-22 Wiedeman Paul E. Oxazolidinone chemotherapeutic agents
JP2004531518A (ja) 2001-04-07 2004-10-14 アストラゼネカ アクチボラグ スルホンイミド基を含有する、抗生物質としてのオキサゾリジノン
KR20040044886A (ko) * 2001-09-11 2004-05-31 아스트라제네카 아베 항균제로서의 옥사졸리디논 및(또는) 이속사졸린
GB2396350A (en) 2001-10-25 2004-06-23 Astrazeneca Ab Aryl substituted oxazolidinones with antibacterial activity
BR0308018A (pt) * 2002-02-28 2005-01-04 Astrazeneca Ab Composto ou um seu sal farmaceuticamente aceitável ou um seu éster hidrolisável in vivo, pró-droga, método para produzir um efeito antibacteriano em um animal de sangue quente, uso de um composto ou um seu sal farmaceuticamente aceitável ou um seu éster hirolisável in vivo, composição farmacêutica, e, processo para a preparação de um composto ou um seu sal farmaceuticamente aceitável ou um seu éster hidrolisável in vivo
IL163688A0 (en) 2002-02-28 2005-12-18 Astrazeneca Ab 3-Cyclyl-5-(nitrogen-containing 5-membered ring)methyl-oxazolidinone derivatives and theiruse as antibacterial agents
WO2004048392A1 (en) 2002-11-28 2004-06-10 Astrazeneca Ab Oxazolidinone and / or isoxazoline derivatives as antibacterial agents
GB0227701D0 (en) 2002-11-28 2003-01-08 Astrazeneca Ab Chemical compounds

Also Published As

Publication number Publication date
WO2004048350A2 (en) 2004-06-10
SA04250095A (ar) 2005-12-03
MXPA05005522A (es) 2005-07-25
US20060116386A1 (en) 2006-06-01
US7498350B2 (en) 2009-03-03
WO2004048350A3 (en) 2004-10-21
JP2006515601A (ja) 2006-06-01
TW200533667A (en) 2005-10-16
AU2003285509A1 (en) 2004-06-18
EP1581524A2 (en) 2005-10-05
CA2507628A1 (en) 2004-06-10
BR0316690A (pt) 2005-10-18
NO20053133D0 (no) 2005-06-27
KR20050084010A (ko) 2005-08-26

Similar Documents

Publication Publication Date Title
NO20053133L (no) Kjemiske forbindelser.
NO20052534L (no) Oksazolidinon- og/eller isokazolinderivater som antibakterielle stoffer
NO20062269L (no) Pyridin-karboksylsyrederivater som glucokinasemodulatorer
NO2015020I2 (no) Ceritinib eller et farmasøytisk akseptabelt salt derav
NO20070032L (no) Hetroarylbenzamid-derivater for anvendelse som GLK-aktivatorer ved behandling av diabetes
DK0958296T3 (da) Heterocykliske forbindelser, fremgangsmåde til deres fremstilling og farmaceutiske præparater, der indeholder dem, og deres anvendelse i behandlingen af diabetes og beslægtede sygdomme
NO20066055L (no) Pyridinderivater
NO20063446L (no) Tiazolderivater
NO20062491L (no) Benzoksazinderivter og deres anvendelse
NO20073926L (no) Pyrazolforbindelser som modulerer aktivitet av CDK-, GSK- og aurorakinaser
NO20073960L (no) Pyrazolderivater for inhibering av CDK og GSK
ATE241617T1 (de) Pyrimidinverbindungen
NO20052038L (no) Ny adeninforbindelse og anvendelse derav
NO20065012L (no) Tetrahydronaftyridin-derivater og fremgangsmate for fremstilling av disse
TW200640900A (en) 1-(2h)-isoquinolone derivative
NO20050666L (no) 2,7-substituerte indoler og deres anvendelse som 5-HT6 modulatorer
ATE377420T1 (de) Phenylalkansäure- und phenyloxyalkansäure- derivate als hppar aktivatore
CY1106358T1 (el) Νεοι δικυκλικοι αναστολεις της ορμονοευαισθητης λιπασης
NO20070157L (no) Substituerte diketopiperaziner som oksytocinantagonister
NO20080110L (no) Benzimidazolderivativer som 5-HT6,5-HT24
NO20063111L (no) Fremgangsmate for fremstilling av tiazolpyrimidiner
NO20043951L (no) 3-cyklyl-5-(nitrogenholdig 5-leddet ring) metyl-oksazolidinon-derivater og deres anvendelse som antibakterielle midler
NO20022123L (no) Osoksazolderivater for anvendelse som inhibitorer for fosfodiesterase VII
TW200510361A (en) Process of preparating 3-acylaminobenzofuran-2-carboxylic acid derivatives
NO20052360L (no) Forbedrede formuleringer inneholdende substituerte imidazolderivater

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application